Earnings Summary

Pacific Biosciences Of California, Inc.’s revenue jumped 34.13% since last year same period to $47.57Mn in the Q2 2023. On a quarterly growth basis, Pacific Biosciences Of California, Inc. has generated 22.3% jump in its revenue since last 3-months.

Pacific Biosciences Of California, Inc.’s net profit jumped 2.19% since last year same period to $-69.83Mn in the Q2 2023. On a quarterly growth basis, Pacific Biosciences Of California, Inc. has generated 13.94% jump in its net profits since last 3-months.

Pacific Biosciences Of California, Inc.’s net profit margin jumped 27.08% since last year same period to -146.79% in the Q2 2023. On a quarterly growth basis, Pacific Biosciences Of California, Inc. has generated 29.63% jump in its net profit margins since last 3-months.

Pacific Biosciences Of California, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.35 - a -6.06% fall from last quarter’s estimates.

Pacific Biosciences Of California, Inc.’s earning per share (EPS) estimates for the current year stand at -0.35.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Pacific Biosciences Of California, Inc.’s return on assets (ROA) stands at -0.1.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Pacific Biosciences Of California, Inc.’s return on equity (ROE) stands at -0.48.